HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mucormycosis: emerging prominence of cutaneous infections.

Abstract
Twenty-five patients with mucormycosis were seen at two university-affiliated hospitals from 1979 to 1993. These cases included 10 cutaneous, 9 rhinocerebral, and 3 disseminated infections, as well as one case each of pulmonary, renal, and peritoneal dialysis catheter-related infection. Eleven of the patients were diabetic and seven had ketoacidosis, including four who became acidotic after admission to the hospital. The mortality rates associated with rhinocerebral, disseminated, and pulmonary infections were 78%-100%, while those associated with cutaneous and miscellaneous forms were zero. In view of the prominence of cutaneous infections, the 10 cases of cutaneous mucormycosis (in addition to a case from a community hospital) are reported in detail. Systemic diseases were present in four of the 11 patients. Local factors leading to infection were identified in nine of the cases and included motor vehicle accident-related and other trauma, surgery, a spider bite, and an intravenous infusion catheter. The cases of cutaneous mucormycosis reported in the literature have been analyzed for identification of predisposing factors, treatment, and outcome. Aggressive surgical debridement is the most important component of therapy, and administration of amphotericin B is a useful adjunct. Skin grafting is useful as a method of repairing defects left by extensive debridement.
AuthorsR D Adam, G Hunter, J DiTomasso, G Comerci Jr
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 19 Issue 1 Pg. 67-76 (Jul 1994) ISSN: 1058-4838 [Print] United States
PMID7948560 (Publication Type: Journal Article, Review)
Chemical References
  • Amphotericin B
Topics
  • Adolescent
  • Adult
  • Aged
  • Amphotericin B (therapeutic use)
  • Brain (microbiology, pathology)
  • Dermatomycoses (physiopathology)
  • Extremities
  • Female
  • Humans
  • Infant
  • Lung (microbiology, pathology)
  • Male
  • Middle Aged
  • Mucorales (isolation & purification)
  • Mucormycosis (drug therapy, physiopathology, surgery)
  • Risk Factors
  • Tibia (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: